RS
Rahul Sharma
OrthoBio Therapeutics UK, AstraZeneca (United Kingdom), University of Rostock, Excalibur Healthcare Services
About
A conscientious scientist with extensive experience in core and translational research with leadership abilities. Adept at various molecular, genomic and cellular techniques such as genome engineering, gene/protein expression, molecular cloning, ELISA/q-PCR/PCR/NGS-based assays and various cell culture methods. Competent with people management and good interpersonal/communication skills.
Employment
-
OrthoBio Therapeutics UK Associate Principal Scientist/Senior Scientist2022 - 2025
-
AstraZeneca (United Kingdom) Laboratory Lead2022 - 2022
-
Excalibur Healthcare Services Principal Scientist/Shift Leader2021 - 2022
-
Avacta Life Sciences Scientist2021 - 2021
-
CignPost Diagnostics Senior Scientist2021 - 2021
-
Charles River Laboratories (United Kingdom) Lab Lead/Scientist2020 - 2021
-
University of Cambridge Research Associate2019 - 2020
-
University of Leeds Research Fellow2015 - 2019
-
University of Rostock Post-doctoral Researcher2014 - 2014
-
University of Rostock Doctoral Researcher2009 - 2014
-
University of Rostock Scientific Researcher2008 - 2009
-
Indian Institute of Toxicology Research CSIR Project Assistant-II2008 - 2008
-
Sanjay Gandhi Post Graduate Institute of Medical Sciences Junior Research Fellow2006 - 2008
Education
-
University of Rostock PhD2009 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility Save
- The single fgf receptor gene in the beetle Tribolium castaneum codes for two isoforms that integrate FGF8-and Branchless-dependent signals Save
- FGF signalling controls anterior extraembryonic and embryonic fate in the beetle Tribolium Save
- The dynamic expression of extraembryonic marker genes in the beetle Tribolium castaneum reveals the complexity of serosa and amnion formation in a short germ insect Save
- Epigenetic modification of suppressor of cytokine signaling-3 in asthmatic mouse lung: role of interleukin-6 Save
- Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease Save